148 related articles for article (PubMed ID: 10344687)
1. Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma.
Kim JC; Han MS; Lee HK; Kim WS; Park SK; Park KC; Bodmer WF; Rowan AJ; Kim OJ
Dis Colon Rectum; 1999 May; 42(5):640-8. PubMed ID: 10344687
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen staining patterns at the invasive tumor margin predict the malignant potential of colorectal carcinoma.
Teixeira CR; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 1994; 51(3):228-33. PubMed ID: 7515172
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of carcinoembryonic antigen as a predictor of lymph node status in submucosa-invasive colorectal carcinoma.
Tokunaga N; Kijima H; Noto T; Osamura Y; Sadahiro S; Tajima T; Mitomi T
Dis Colon Rectum; 1995 Aug; 38(8):842-7. PubMed ID: 7543404
[TBL] [Abstract][Full Text] [Related]
4. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of carcinoembryonic antigen distribution in tumor tissue of colorectal carcinoma.
Nazato DM; Matos LL; Waisberg DR; Souza JR; Martins LC; Waisberg J
Arq Gastroenterol; 2009; 46(1):26-31. PubMed ID: 19466306
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas.
Choi HJ; Jung IK; Kim SS; Hong SH
Dis Colon Rectum; 1997 Jan; 40(1):51-9. PubMed ID: 9102262
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for recurrence in stage II/III colorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern.
Tokodai K; Narimatsu H; Nishida A; Takaya K; Hara Y; Kawagishi N; Hashizume E; Ohuchi N
J Surg Oncol; 2016 Sep; 114(3):368-74. PubMed ID: 27264681
[TBL] [Abstract][Full Text] [Related]
8. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
Morita S; Nomura T; Fukushima Y; Morimoto T; Hiraoka N; Shibata N
Dis Colon Rectum; 2004 Feb; 47(2):227-32. PubMed ID: 15043294
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of lymph node skip metastasis in Stage III colorectal cancer.
Bao F; Zhao LY; Balde AI; Liu H; Yan J; Li TT; Chen H; Li GX
Colorectal Dis; 2016 Sep; 18(9):O322-9. PubMed ID: 27438774
[TBL] [Abstract][Full Text] [Related]
10. Use of the preoperative levels of CEA in patients with colorectal cancer.
Marchena J; Acosta MA; Garcia-Anguiano F; Simpson H; Cruz F
Hepatogastroenterology; 2003; 50(52):1017-20. PubMed ID: 12845969
[TBL] [Abstract][Full Text] [Related]
11. Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes a and B colorectal cancer: results of a five-year study.
Miki C; Inoue Y; Hiro J; Ojima E; Araki T; Uchida K; Kusunoki M
Dis Colon Rectum; 2006 Nov; 49(11):1710-8. PubMed ID: 16990975
[TBL] [Abstract][Full Text] [Related]
12. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma.
Diez M; Pollan M; Müguerza JM; Gaspar MJ; Duce AM; Alvarez MJ; Ratia T; Herñandez P; Ruiz A; Granell J
Cancer; 2000 Jan; 88(1):35-41. PubMed ID: 10618603
[TBL] [Abstract][Full Text] [Related]
13. CEA tissue staining in colorectal cancer patients--correlation with plasma CEA, histology and staging.
Ng IO; Ho J; Pritchett CJ; Chan EY; Ho FC
Pathology; 1993 Jul; 25(3):219-22. PubMed ID: 8265235
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
15. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen gene and carcinoembryonic antigen expression in the liver metastasis of colorectal carcinoma.
Kim JC; Gong G; Roh SA; Park KC
Mol Cells; 1999 Apr; 9(2):133-7. PubMed ID: 10340466
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF
Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of carcinoembryonic antigen messenger ribonucleic acid expression in tumor-draining vein blood on postoperative liver metastasis in patients with colorectal carcinoma: a prospective, cohort study.
Sunouchi K; Machinami R; Mori M; Namiki K; Hattori S; Murata Y; Tsuchiya T; Mizuno H; Tadokoro M
Dis Colon Rectum; 2003 Apr; 46(4):467-73. PubMed ID: 12682539
[TBL] [Abstract][Full Text] [Related]
20. [Carcinoembryonic antigen in diagnosis and monitoring of colorectal cancer].
Forones NM; Tanaka M; Machado D; Falcão JB; Giovanoni M
Arq Gastroenterol; 1997; 34(1):3-6. PubMed ID: 9458953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
